Literature DB >> 8977404

Neuropeptide Y induced feeding in the rat is mediated by a novel receptor.

D O'Shea1, D G Morgan, K Meeran, C M Edwards, M D Turton, S J Choi, M M Heath, I Gunn, G M Taylor, J K Howard, C I Bloom, C J Small, O Haddo, J J Ma, W Callinan, D M Smith, M A Ghatei, S R Bloom.   

Abstract

There are now six recognized neuropeptide Y (NPY) receptor subtypes (Y1-Y4 and two recently cloned distinct receptors labeled Y5), of which Y1 and one of the Y5's have been suggested could mediate the effect of NPY on feeding. The fragments NPY(2-36) and NPY(3-36), which bind Y1 only poorly, were injected intracerebroventricularly (icv) and found to have similar dose-response relationships to NPY in the stimulation of feeding. However NPY (13-36), which stimulates both Y2 and Y5, caused no increase in food intake, even at high doses. Maximal stimulation with the classical Y1 agonist [Pro34]-NPY produced only 50% of the maximum effect of NPY itself despite fully inhibiting adenylyl cyclase activity in vitro in a Y1 system. The novel fragment [Pro34]-NPY(3-36) is as effective at stimulating food intake as the classical Y1 analogue [Pro34]-NPY but bound to the Y1 receptor with only 1/20th of the affinity of NPY and failed to inhibit adenylyl cyclase through this receptor. [Pro34]-NPY(3-36) is therefore a relatively appetite-selective ligand. Coadministration of high dose NPY(13-36) and [Pro34]NPY did not enhance feeding compared with [Pro34]-NPY alone. In addition, the NPY Y1 receptor antagonist BIBP-3226, which does not bind Y2, Y4, or Y5 receptors, significantly reduced NPY induced feeding. These results indicate that the feeding effect of icv NPY involves a novel receptor and that it is functionally distinct from the recognized receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8977404     DOI: 10.1210/endo.138.1.4899

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  17 in total

1.  Peptide analogue studies of the hypothalamic neuropeptide Y receptor mediating pituitary adrenocorticotrophic hormone release.

Authors:  C J Small; D G Morgan; K Meeran; M M Heath; I Gunn; C M Edwards; J Gardiner; G M Taylor; J D Hurley; M Rossi; A P Goldstone; D O'Shea; D M Smith; M A Ghatei; S R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

3.  The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin.

Authors:  M S Kim; C J Small; S A Stanley; D G Morgan; L J Seal; W M Kong; C M Edwards; S Abusnana; D Sunter; M A Ghatei; S R Bloom
Journal:  J Clin Invest       Date:  2000-04       Impact factor: 14.808

4.  Suppression of third ventricular NPY-elicited feeding following medullary reticular formation infusions of muscimol.

Authors:  Joseph B Travers; Kenneth Herman; Susan P Travers
Journal:  Behav Neurosci       Date:  2010-04       Impact factor: 1.912

5.  Orexigenic response to tail pinch: role of brain NPY(1) and corticotropin releasing factor receptors.

Authors:  Miriam Goebel-Stengel; Andreas Stengel; Lixin Wang; Yvette Taché
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-12-11       Impact factor: 3.619

6.  Central injection of the stable somatostatin analog ODT8-SST induces a somatostatin2 receptor-mediated orexigenic effect: role of neuropeptide Y and opioid signaling pathways in rats.

Authors:  Andreas Stengel; Tamer Coskun; Miriam Goebel; Lixin Wang; Libbey Craft; Jorge Alsina-Fernandez; Jean Rivier; Yvette Taché
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

7.  Adrenalectomy reduces neuropeptide Y-induced insulin release and NPY receptor expression in the rat ventromedial hypothalamus.

Authors:  T Wisialowski; R Parker; E Preston; A Sainsbury; E Kraegen; H Herzog; G Cooney
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

8.  Evolution of the neuropeptide Y receptor family: gene and chromosome duplications deduced from the cloning and mapping of the five receptor subtype genes in pig.

Authors:  A Wraith; A Törnsten; P Chardon; I Harbitz; B P Chowdhary; L Andersson; L G Lundin; D Larhammar
Journal:  Genome Res       Date:  2000-03       Impact factor: 9.043

9.  Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.

Authors:  L Criscione; P Rigollier; C Batzl-Hartmann; H Rüeger; A Stricker-Krongrad; P Wyss; L Brunner; S Whitebread; Y Yamaguchi; C Gerald; R O Heurich; M W Walker; M Chiesi; W Schilling; K G Hofbauer; N Levens
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

10.  The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.

Authors:  Yih-Shou Hsieh; Meng-Hsien Kuo; Pei-Ni Chen; Dong-Yih Kuo
Journal:  Neuromolecular Med       Date:  2012-11-20       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.